Evaluation of the correct use of levothyroxine in patients with hypothyroidism

Ayşe Arslan, C. Ardic, Kerem Uzun, S. Karakullukçu
{"title":"Evaluation of the correct use of levothyroxine in patients with hypothyroidism","authors":"Ayşe Arslan, C. Ardic, Kerem Uzun, S. Karakullukçu","doi":"10.15511/TJTFP.21.00257","DOIUrl":null,"url":null,"abstract":"Ýntroduction: Standard treatment for hypothyroidism is replacement with synthetic Levothyroxine (LT4) sodium preparations. LT4 should be taken on an empty stomach at least 30 minutes before a meal, as maximal absorption occurs when taken on an empty stomach. Protein Pump Inhibitor (PPI), iron sulphate, calcium carbonate have been shown to reduce the absorption of LT4 when taken together with LT4. Therefore, patients receiving LT4 should be informed to take their drugs at least 4 hours before drugs that interact with thyroid hormone absorption. \n \nObjective: The aim of this study is to evaluate the correct use of levothyroxine drug, which is widely used in the society, in patients with hypothyroidism, to reveal the reasons for misuse, and to associate the number of drugs used by patients, types and chronic diseases. \n \nMaterial and method: Our study was conducted with a face-to-face questionnaire consisting of 18 questions in patients who applied to Recep Tayyip Erdoðan University Education and Research Hospital Endocrinology and Metabolic Diseases Polyclinic and Family Medicine outpatient clinic between 10-20 June 2020 and used LT4 due to any reason of hypothyroidism, and by obtaining patient consent. \n \nResults: 103 patients, 15 men and 88 women, participated in our study. 103 (100%) of the patients participating in our study took their medication in the morning and stored it in the right place. 94 of them (91.3%) took their medication regularly. 92 of them (89.3%) used their medicine at least 30 minutes before the meal. 60 of the patients (58.25%) used their medication correctly. 18 (41.9%) of the 43 people who used wrong medication were using PPI, 7 (16.3%) calcium carbonate, 5 (11.6%) ferrous sulfate. When compared in terms of correct use, a statistically significant difference (p","PeriodicalId":22867,"journal":{"name":"The Journal of Turkish Family Physician","volume":"14 1","pages":"57-65"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Turkish Family Physician","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15511/TJTFP.21.00257","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Ýntroduction: Standard treatment for hypothyroidism is replacement with synthetic Levothyroxine (LT4) sodium preparations. LT4 should be taken on an empty stomach at least 30 minutes before a meal, as maximal absorption occurs when taken on an empty stomach. Protein Pump Inhibitor (PPI), iron sulphate, calcium carbonate have been shown to reduce the absorption of LT4 when taken together with LT4. Therefore, patients receiving LT4 should be informed to take their drugs at least 4 hours before drugs that interact with thyroid hormone absorption. Objective: The aim of this study is to evaluate the correct use of levothyroxine drug, which is widely used in the society, in patients with hypothyroidism, to reveal the reasons for misuse, and to associate the number of drugs used by patients, types and chronic diseases. Material and method: Our study was conducted with a face-to-face questionnaire consisting of 18 questions in patients who applied to Recep Tayyip Erdoðan University Education and Research Hospital Endocrinology and Metabolic Diseases Polyclinic and Family Medicine outpatient clinic between 10-20 June 2020 and used LT4 due to any reason of hypothyroidism, and by obtaining patient consent. Results: 103 patients, 15 men and 88 women, participated in our study. 103 (100%) of the patients participating in our study took their medication in the morning and stored it in the right place. 94 of them (91.3%) took their medication regularly. 92 of them (89.3%) used their medicine at least 30 minutes before the meal. 60 of the patients (58.25%) used their medication correctly. 18 (41.9%) of the 43 people who used wrong medication were using PPI, 7 (16.3%) calcium carbonate, 5 (11.6%) ferrous sulfate. When compared in terms of correct use, a statistically significant difference (p
甲状腺功能减退患者正确使用左旋甲状腺素的评价
Ýntroduction:甲状腺功能减退的标准治疗是用合成左甲状腺素(LT4)钠制剂替代。LT4应在餐前至少30分钟空腹服用,因为空腹时吸收效果最好。蛋白质泵抑制剂(PPI)、硫酸铁、碳酸钙与LT4一起服用可减少LT4的吸收。因此,应告知接受LT4治疗的患者在药物与甲状腺激素吸收相互作用前至少4小时服药。目的:本研究旨在评价社会上广泛使用的左旋甲状腺素药物在甲状腺功能减退患者中的正确使用情况,揭示误用原因,并将患者用药数量、用药类型与慢性疾病联系起来。材料和方法:我们的研究采用面对面的问卷调查,包括18个问题,患者于2020年6月10日至20日期间在雷杰普·塔伊普·埃尔多安大学教育与研究医院内分泌与代谢疾病综合诊所和家庭医学门诊就诊,并因甲状腺功能减退而使用LT4,并获得患者同意。结果:103例患者参与了我们的研究,其中男性15例,女性88例。103例(100%)参与我们研究的患者在早上服药并将其存放在正确的地方。其中94人(91.3%)定期服药。其中92人(89.3%)在饭前至少30分钟服药。60例患者(58.25%)正确用药。43例用药错误患者中,PPI 18例(41.9%),碳酸钙7例(16.3%),硫酸亚铁5例(11.6%)。当在正确使用方面进行比较时,统计学上有显著差异(p
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信